Name
osaühing Saaremaa Apteek
Registry code
10021256
VAT number
EE100487387
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
22.04.1996 (28)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
938 024 €
-15 202 €
-2%
1 612 €
(estimate is approximate)
29 079 €
5
Submitted
No tax arrears
-52%
-8%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Maarja Tiitson 12.02.1990 (34) | 100% - 2 500.00 EUR | Board member | Direct ownership |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Saaremaa vald, Kuressaare linn, K. Ojassoo tn 2, K. Ojassoo tn 4 korteriühistu 80073421 | - | - | - | Founder |
| 2019 20.05.2020 | 2020 17.05.2021 | 2021 30.06.2022 | 2022 26.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 1 288 606 € | 1 194 265 € | 1 067 461 € | 1 011 143 € | 938 024 € |
| Net profit (loss) for the period | 20 005 € | -13 760 € | -18 741 € | 43 341 € | -15 202 € |
| Profit Margin | 2% | -1% | -2% | 4% | -2% |
| Current Assets | 234 159 € | 226 758 € | 189 151 € | 204 136 € | 182 795 € |
| Fixed Assets | 163 € | 1 366 € | 1 080 € | 56 536 € | 1 082 € |
| Total Assets | 234 322 € | 228 124 € | 190 231 € | 260 672 € | 183 877 € |
| Current Liabilities | 170 881 € | 178 443 € | 159 291 € | 186 391 € | 154 798 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 63 441 € | 49 681 € | 30 940 € | 74 281 € | 29 079 € |
| Employees | 8 | 8 | 7 | 6 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 223 129.62 € | 15 062.45 € | 11 542.44 € | 5 |
| 2023 Q4 | 213 421.91 € | 15 423.28 € | 11 813.26 € | 5 |
| 2023 Q3 | 242 661.01 € | 25 190.88 € | 12 570.02 € | 5 |
| 2023 Q2 | 249 216.47 € | 16 778.67 € | 13 126.55 € | 5 |
| 2023 Q1 | 252 612.37 € | 18 784.71 € | 13 266.85 € | 6 |
| 2022 Q4 | 234 991.44 € | 17 347.22 € | 13 166.28 € | 6 |
| 2022 Q3 | 274 625.23 € | 20 998.73 € | 15 369.35 € | 6 |
| 2022 Q2 | 244 449.67 € | 18 365.19 € | 13 720.54 € | 6 |
| 2022 Q1 | 246 983.76 € | 18 441.16 € | 13 464.68 € | 6 |
| 2021 Q4 | 249 479.19 € | 18 050.46 € | 14 212.34 € | 6 |
| 2021 Q3 | 285 614.94 € | 23 728.53 € | 17 534.48 € | 6 |
| 2021 Q2 | 241 424.24 € | 17 870.76 € | 14 037.02 € | 6 |
| 2021 Q1 | 299 783.61 € | 21 498.32 € | 16 970.47 € | 8 |
| 2020 Q4 | 289 902.04 € | 18 819.94 € | 15 070.79 € | 8 |
| 2020 Q3 | 304 460.95 € | 24 294.09 € | 18 334.55 € | 8 |
| 2020 Q2 | 270 840.24 € | 15 581.71 € | 12 636.8 € | 8 |
| 2020 Q1 | 340 427.99 € | 22 352.68 € | 16 419 € | 8 |
